AU2002224848A1 - Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition - Google Patents

Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition

Info

Publication number: AU2002224848A1
Authority: AU; Australia
Prior art keywords: nutrition; ill; malnutrition; supplement; people
Prior art date: 2000-11-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002224848A

Other versions

AU2002224848B2 (en

Inventor

Barbara Kessler

Angelika Riedel

Ulrich Suchner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fresenius Kabi Deutschland GmbH

Original Assignee

Fresenius Kabi Deutschland GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-17

Filing date

2001-11-14

Publication date

2002-08-01

2000-11-17 Priority claimed from DE10057290A external-priority patent/DE10057290B4/en

2001-11-14 Application filed by Fresenius Kabi Deutschland GmbH filed Critical Fresenius Kabi Deutschland GmbH

2002-08-01 Publication of AU2002224848A1 publication Critical patent/AU2002224848A1/en

2006-06-15 Application granted granted Critical

2006-06-15 Publication of AU2002224848B2 publication Critical patent/AU2002224848B2/en

2021-11-14 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002224848A 2000-11-17 2001-11-14 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition Ceased AU2002224848B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10057290.1		2000-11-17
DE10057290A DE10057290B4 (en)	2000-11-17	2000-11-17	Enteral supplement for parenteral nutrition or partial enteral / oral nutrition for critically ill, chronically ill and malnourished
PCT/EP2001/013163 WO2002039978A1 (en)	2000-11-17	2001-11-14	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition

Publications (2)

Publication Number	Publication Date
AU2002224848A1 true AU2002224848A1 (en)	2002-08-01
AU2002224848B2 AU2002224848B2 (en)	2006-06-15

Family

ID=7663817

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2484802A Pending AU2484802A (en)	2000-11-17	2001-11-14	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
AU2002224848A Ceased AU2002224848B2 (en)	2000-11-17	2001-11-14	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2484802A Pending AU2484802A (en)	2000-11-17	2001-11-14	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition

Country Status (28)

Country	Link
US (1)	US7947303B2 (en)
EP (1)	EP1337236B1 (en)
JP (1)	JP2004513912A (en)
KR (2)	KR20080069280A (en)
CN (1)	CN1477950A (en)
AT (1)	ATE272390T1 (en)
AU (2)	AU2484802A (en)
BR (1)	BRPI0115451B1 (en)
CA (1)	CA2429270C (en)
CZ (1)	CZ300129B6 (en)
DE (2)	DE10057290B4 (en)
DK (1)	DK1337236T3 (en)
EE (1)	EE05209B1 (en)
ES (1)	ES2223015T3 (en)
HR (1)	HRP20030395B1 (en)
HU (1)	HU228351B1 (en)
IL (2)	IL155840A0 (en)
IS (1)	IS2377B (en)
MX (1)	MXPA03004348A (en)
NO (1)	NO333003B1 (en)
NZ (1)	NZ525812A (en)
PL (1)	PL202031B1 (en)
PT (1)	PT1337236E (en)
RU (1)	RU2295952C2 (en)
SI (1)	SI1337236T1 (en)
SK (1)	SK286199B6 (en)
WO (1)	WO2002039978A1 (en)
ZA (1)	ZA200303722B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10254584A1 (en) *	2002-11-22	2004-06-09	HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie	Use of medium chain triglycerides (MCT) for nutritional optimization of the fatty acid spectrum in a dietetic food for diabetics
US20070026090A1 (en) *	2003-09-05	2007-02-01	Oren Tirosh	Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
AU2004273759A1 (en) *	2003-09-19	2005-03-31	N.V. Nutricia	Method and composition for preventing multiple organ dysfunction syndrome
DE10349585A1 (en)	2003-10-24	2005-06-16	Biosyn Arzneimittel Gmbh	Trace element composition for the diet
DE202004015931U1 (en) *	2004-10-13	2005-01-05	Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh	Composition containing omega-3 fatty acids and omega-6 fatty acids
US20050148669A1 (en) *	2004-10-21	2005-07-07	Daniel Amato	Amino acid esters as nutrient supplements and methods of use
EP1814394A4 (en) *	2004-11-09	2009-08-19	Hills Pet Nutrition Inc	Use of antioxidants for gene modulation
BRPI0519755A2 (en) *	2004-12-21	2009-03-10	Critical Care Connections Inc	therapeutic nutrient compositions or combinations and their use
ES2488128T5 (en) *	2005-04-27	2022-11-15	Nutricia Nv	Nutrition with lipids and indigestible saccharides
EP1719543A1 (en) *	2005-05-04	2006-11-08	Asan Labs., Ltd.	Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2006127695A2 (en) *	2005-05-23	2006-11-30	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Ascorbic acid conjugates
CA2620366C (en)	2005-08-26	2014-04-01	Nestec S.A.	Nutrition for obese patients
DE102005046237A1 (en) *	2005-09-28	2007-04-05	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Use of butyrate esters of carbohydrates or carbohydrate polyols as butyrate source for the digestive tract, useful for prevention and treatment of gastrointestinal diseases in humans and animals
AU2006316059A1 (en) *	2005-11-15	2007-05-24	Entress Ab	Medicament for use in connection with cartilage impairment
US20090011077A1 (en) *	2006-01-09	2009-01-08	Nestec S.A.	Treatment of Stressed Patients
US20100215631A1 (en) *	2006-06-14	2010-08-26	Anita Hartog	Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
MY148671A (en) *	2006-10-19	2013-05-31	Nestec Sa	Long-term enteral feed for maintenance
KR100774816B1 (en) *	2006-11-21	2007-11-07	동부일렉트로닉스 주식회사	Manufacturing method and structure of MIM capacitor of semiconductor device
EP2428125B1 (en) *	2007-09-17	2017-05-17	N.V. Nutricia	Nutritional formulation with high energy content
EP2205235A4 (en) *	2007-10-14	2010-11-17	Univ Florida	FORMULATION FOR IMPROVING THE MAGIC DARM FUNCTION
RU2354380C1 (en) *	2007-11-16	2009-05-10	Государственное образовательное учреждение высшего профессионального образования "Омская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Росздрава"	Method of medicamental correction of vasomotor endothelium function in children with sugar diabetes of type 1, who do not have microangiopathies
RU2394583C1 (en) *	2008-12-01	2010-07-20	Марк Абович Малков	Agent for prevention of metabolic derangement
IT1396935B1 (en) *	2009-11-26	2012-12-20	Solartium Entpr Ltd	USE OF A COMBINATION FOR THE TREATMENT OF MUCOSITES INDUCED BY RADIATION OR CHEMOTHERAPY
WO2011139621A1 (en) *	2010-04-26	2011-11-10	Nestec S.A.	Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
CN103458887A (en) *	2011-03-31	2013-12-18	雀巢产品技术援助有限公司	Nutritional compositions for increasing arginine levels and methods of using same
KR102100091B1 (en) *	2011-04-13	2020-04-14	아지노모토 가부시키가이샤	Nutritional composition
US8183227B1 (en)	2011-07-07	2012-05-22	Chemo S. A. France	Compositions, kits and methods for nutrition supplementation
US8168611B1 (en)	2011-09-29	2012-05-01	Chemo S.A. France	Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) *	2011-10-11	2013-04-17	Nestec S.A.	Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en)	2013-09-16	2017-12-26	Healios Oncology Nutrition, LLC	Glutamine and trehalose compositions
TW201717931A (en)	2015-06-10	2017-06-01	Ajinomoto Kk	Ameliorating agent for exercise-induced gastrointestinal disorders
ES2638195B1 (en) *	2016-04-18	2018-08-02	Bioiberica, S.A.	SKIN COMPOSITIONS
CN116779143A (en)	2017-05-09	2023-09-19	巴克斯特国际公司	Parenteral nutrition diagnostic systems, devices and methods
CN108208177A (en) *	2017-11-28	2018-06-29	上海交通大学医学院附属新华医院	Composition and its application containing butyric acid compound
PL423673A1 (en) *	2017-12-01	2019-06-03	Lewandowska Agata	Composition for oral administration, application of the composition in prevention and therapy of mucositis and method for treatment of mucositis
EP4102998A1 (en) *	2020-02-12	2022-12-21	DSM IP Assets B.V.	Direct delivery of antioxidants to the gut
WO2021191469A1 (en) *	2020-03-27	2021-09-30	Basf Se	Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en)	2020-06-05	2023-06-06	Baxter International Inc.	Parenteral nutrition formulation
US20220160669A1 (en)	2020-11-24	2022-05-26	Baxter International Inc.	Parenteral nutrition formulation
DE202021102589U1 (en)	2020-12-15	2021-05-28	Marco Lautenschläger	Ready-to-eat, bottled drink based on natural mineral water
US20250195547A1 (en) *	2022-04-19	2025-06-19	Vanderbilt University	Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) *	2022-05-06	2023-11-09	Ageless Sciences, Inc.	Compositions and methods for slowing down aging and extending lifespan
CN116920075B (en) *	2023-09-15	2024-01-02	潍坊市人民医院(潍坊市公共卫生临床中心)	Enteral nutrient solution and preparation method thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3698912A (en) *	1969-07-01	1972-10-17	Morton Norwich Products Inc	Process for making nutrient composition
DE3135849A1 (en) *	1981-09-10	1983-03-17	Dr. Schumacher GmbH & Co KG, 4600 Dortmund	COATING MATERIAL FOR CORROSION PROTECTION PURPOSES
US4446389A (en) *	1982-03-15	1984-05-01	Ampex Corporation	Quadrature tach decoder circuit
CA1285491C (en) *	1985-09-12	1991-07-02	Robert J. Smith	Method of treating catabolic dysfunction
ES2007350A6 (en) *	1987-05-29	1989-06-16	Ganadera Union Ind Agro	FOOD PRODUCTS ENRICHED WITH NUCLEOSIDES AND NOT NUCLEOTIDES FOR THE NUTRITION OF CHILDREN AND ADULTS, AND PROCEDURE FOR THEIR PREPARATION.
IL94549A (en) *	1989-06-02	1996-08-04	Brigham & Womens Hospital	Pharmaceutical composition containing glutamine
AU645070B2 (en) *	1990-04-10	1994-01-06	Nb International Technologies	Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (en) *	1990-08-24	1990-08-24	Kabivitrum Ab	PRODUCT CONTAINING GROWTH FACTOR
JP2524551B2 (en) *	1992-02-28	1996-08-14	雪印乳業株式会社	Peptide composition having high glutamine content, method for producing the same, and enteral nutritional supplement
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases
ES2173109T3 (en) *	1992-12-23	2002-10-16	Abbott Lab	FOODS OF A MEDICAL UNDERSTANDED FOR NUTRITIONAL SUSTAINMENT OF NEWBORNS / BABIES WHO ARE LIVING WITH METABOLIC DISEASES.
JP4059532B2 (en) *	1994-08-15	2008-03-12	森永乳業株式会社	Peptide mixture that prevents intestinal bacteria from entering the body, and a composition containing this peptide mixture
US5719133A (en) *	1994-09-21	1998-02-17	Novartis Nutrition Ag	Adolescent dietary composition
JP4011638B2 (en) *	1994-12-27	2007-11-21	イーエヌ大塚製薬株式会社	Oral enteral nutrition composition
US5569680A (en) *	1995-02-13	1996-10-29	Trustees Of The Univ. Of Penna	Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (en) *	1995-08-03	1997-02-06	Braun Melsungen Ag	Preparation for nutrition
JPH09323979A (en) *	1996-06-04	1997-12-16	Meiji Milk Prod Co Ltd	Immunomodulatory composition using nucleic acid
GB9701674D0 (en) *	1997-01-28	1997-03-19	Novartis Nutrition Ag	Use of organic compounds
US6124486A (en) *	1997-01-31	2000-09-26	Eastman Chemical Company	Process for making low calorie triglycerides having long and short fatty acid chains
AU2089297A (en) *	1997-03-17	1998-10-12	Yun K. Tam	Composition for prevention of hepatic steatosis
GB9709082D0 (en) *	1997-05-06	1997-06-25	Ciba Geigy Ag	Organic compositions
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
EP0891719A1 (en) *	1997-07-14	1999-01-20	N.V. Nutricia	Nutritional composition containing methionine
AU2186699A (en) *	1998-02-09	1999-08-23	Meiji Milk Products Co., Ltd.	Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) *	1998-02-26	2002-04-09	The University Of Georgia Research Foundation, Inc.	Structured lipids
WO2000015043A1 (en) *	1998-09-11	2000-03-23	Danisco Cultor America, Inc.	Reduced calorie plastic fat composition
JP2000119180A (en) *	1998-10-06	2000-04-25	Nisshin Flour Milling Co Ltd	Enteral nutrient
US7115297B2 (en) *	2000-02-22	2006-10-03	Suzanne Jaffe Stillman	Nutritionally fortified liquid composition with added value delivery systems/elements/additives

2000
- 2000-11-17 DE DE10057290A patent/DE10057290B4/en not_active Expired - Fee Related
2001
- 2001-11-14 CZ CZ20031337A patent/CZ300129B6/en not_active IP Right Cessation
- 2001-11-14 AU AU2484802A patent/AU2484802A/en active Pending
- 2001-11-14 RU RU2003117716/15A patent/RU2295952C2/en not_active IP Right Cessation
- 2001-11-14 SI SI200130195T patent/SI1337236T1/en unknown
- 2001-11-14 CN CNA018200478A patent/CN1477950A/en active Pending
- 2001-11-14 KR KR1020087017023A patent/KR20080069280A/en not_active Ceased
- 2001-11-14 HR HR20030395A patent/HRP20030395B1/en not_active IP Right Cessation
- 2001-11-14 EP EP01994656A patent/EP1337236B1/en not_active Expired - Lifetime
- 2001-11-14 ES ES01994656T patent/ES2223015T3/en not_active Expired - Lifetime
- 2001-11-14 PL PL361634A patent/PL202031B1/en unknown
- 2001-11-14 WO PCT/EP2001/013163 patent/WO2002039978A1/en active IP Right Grant
- 2001-11-14 BR BRPI0115451A patent/BRPI0115451B1/en not_active IP Right Cessation
- 2001-11-14 DE DE50103152T patent/DE50103152D1/en not_active Expired - Lifetime
- 2001-11-14 CA CA002429270A patent/CA2429270C/en not_active Expired - Fee Related
- 2001-11-14 HU HU0301386A patent/HU228351B1/en not_active IP Right Cessation
- 2001-11-14 KR KR1020037006682A patent/KR100861889B1/en not_active Expired - Fee Related
- 2001-11-14 JP JP2002542353A patent/JP2004513912A/en active Pending
- 2001-11-14 PT PT01994656T patent/PT1337236E/en unknown
- 2001-11-14 SK SK561-2003A patent/SK286199B6/en not_active IP Right Cessation
- 2001-11-14 AU AU2002224848A patent/AU2002224848B2/en not_active Ceased
- 2001-11-14 AT AT01994656T patent/ATE272390T1/en active
- 2001-11-14 IL IL15584001A patent/IL155840A0/en unknown
- 2001-11-14 NZ NZ525812A patent/NZ525812A/en not_active IP Right Cessation
- 2001-11-14 US US10/432,915 patent/US7947303B2/en not_active Expired - Fee Related
- 2001-11-14 MX MXPA03004348A patent/MXPA03004348A/en active IP Right Grant
- 2001-11-14 EE EEP200300198A patent/EE05209B1/en unknown
- 2001-11-14 DK DK01994656T patent/DK1337236T3/en active
2003
- 2003-05-11 IL IL155840A patent/IL155840A/en not_active IP Right Cessation
- 2003-05-13 NO NO20032160A patent/NO333003B1/en not_active IP Right Cessation
- 2003-05-14 IS IS6815A patent/IS2377B/en unknown
- 2003-05-14 ZA ZA200303722A patent/ZA200303722B/en unknown

Publication	Publication Date	Title
AU2002224848A1 (en)	2002-08-01	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
HUP0301386A3 (en)	2008-04-28	Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill. the chronically ill and people with malnutrition
ATE290320T1 (en)	2005-03-15	INFANT NUTRITION SUPPLEMENT WITH IMPROVED PROTEIN CONTENT
DE60233346D1 (en)	2009-09-24	SMALL CHILDREN'S FOOD NUTRITION WITH INCREASED ALPHA-LACTALBUMIN CONTENT
CY1107547T1 (en)	2013-03-13	CHROME-STEIN COMPLEXES AS NUTRITIONAL SUPPLEMENTS
AU7828200A (en)	2001-04-24	Nutritional supplement for increased energy and stamina
AU2003245947A1 (en)	2003-12-31	Use of alkylamidomandelates as flavourings
DE69939900D1 (en)	2008-12-24	INSULIN ENRICHED INFANT NUTRITIONAL PREPARATION
MXPA05003732A (en)	2005-09-30	Methods and compositions for providing glutamine.
DE69910990D1 (en)	2003-10-09	FOOD WITH BIOTIN AND OTHER B-VITAMINS
MXPA04003499A (en)	2004-07-30	Use of cystathionine.
MXPA00003232A (en)	2004-03-10	Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects.
WO2006130844A3 (en)	2007-11-29	Fucoidan delivery system
AU2001275144A1 (en)	2001-12-11	Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
HUP0400924A3 (en)	2007-11-28	Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
CA2395530A1 (en)	2001-06-28	Calcium formate for use as a phosphorus binder and a dietary supplement
NO20004224L (en)	2000-10-23	Use of D-tagatosis as a prebiotic food component
AU2216901A (en)	2001-07-16	Dietary supplement
Cochran	2000	10 tips for great nutrition: Slash your sodium intake
WO2001028570A3 (en)	2001-11-01	Zinc lactate lozenges and uses thereof
AU2002328029A1 (en)	2003-04-22	Pharmaceutical product or food supplement and intermediate product to be used therewith
HK1017238A (en)	1999-11-19	Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
UA41060A (en)	2001-08-15	Method for correcting intestinal dysbioses in children with chronic parenteral pathology
AU2001281611A1 (en)	2002-03-04	Process of preparation and administration of dietary complement
PL326733A1 (en)	1999-12-20	Dietary article of food for supplementing human diet with magnesium